The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Retrospective Study of MRI in Pediatric Patients
Official Title: The Safety and Efficacy of MULTIHANCE at the Dose of 0.10 mmol/kg in Magnetic Resonance Imaging of the Central Nervous System in Pediatric Patients Who Are Less Than 2 Years of Age
Study ID: NCT02291822
Brief Summary: Collection of already existing data and images for patients \< 2 years of age having MultiHance administration for a MRI of the brain or spine. MR Images will be reviewed during a prospectively designed blinded reading of the images.
Detailed Description:
Minimum Age:
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Name: Gianpaolo Priovano, M.D.
Affiliation: Bracco Diagnostics, Inc
Role: STUDY_DIRECTOR